LPL Financial
AQST icon

LPL Financial’s Aquestive Therapeutics AQST Stock Holding History

LPL Financial’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$345K Sell
83,213
-19,175
-19% -$77.8K ﹤0.01% 5089
2025
Q4 		$661K Buy
102,388
+12,500
+14% +$77.9K ﹤0.01% 4462
2025
Q3 		$502K Buy
89,888
+12,000
+15% +$51.9K ﹤0.01% 4622
2025
Q2 		$258K Buy
+77,888
New +$223K ﹤0.01% 4889
2024
Q3 		– Sell
-10,113
Closed -$26.3K – 5169
2024
Q2 		$26.3K Sell
10,113
-44,130
-81% -$147K ﹤0.01% 4913
2024
Q1 		$231K Buy
+54,243
New +$181K ﹤0.01% 4395

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return